Soliton, Inc. (SOLY) Financial Statements (2024 and earlier)

Company Profile

Business Address 5304 ASHBROOK DRIVE
HOUSTON, TX 77081
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q3
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,58826,05231,55734,62637,3067,545
Cash and cash equivalents20,58826,05231,55734,62637,3067,545
Restricted cash and investments200200 200200200
Receivables6932159210788420
Inventory, net of allowances, customer advances and progress billings88599 266171 
Inventory88599 266171 
Other undisclosed current assets427514602207341494
Total current assets:21,99627,58032,25135,40638,1068,658
Noncurrent Assets
Property, plant and equipment2,4311,8321,4131,334828786
Intangible assets, net (including goodwill)31028311412911298
Intangible assets, net (excluding goodwill)31028311412911298
Other noncurrent assets   23 2323
Total noncurrent assets:2,7412,1151,5501,463963908
TOTAL ASSETS:24,73729,69533,80136,86939,0699,565
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,3232,8031,0082,3451,7091,850
Accounts payable2,1671,3081,008655782989
Accrued liabilities2,1561,495 1,690927861
Other undisclosed current liabilities   1,812   
Total current liabilities:4,3232,8032,8202,3451,7091,850
Noncurrent Liabilities
Liabilities, other than long-term debt      1
Deferred revenue      1
Total noncurrent liabilities:      1
Total liabilities:4,3232,8032,8202,3451,7091,851
Equity
Equity, attributable to parent20,41426,89230,98134,52437,3607,714
Common stock222121212117
Additional paid in capital104,041102,632101,544100,54699,78967,011
Accumulated deficit(83,649)(75,761)(70,584)(66,043)(62,450)(59,314)
Total equity:20,41426,89230,98134,52437,3607,714
TOTAL LIABILITIES AND EQUITY:24,73729,69533,80136,86939,0699,565

Income Statement (P&L) ($ in thousands)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q3
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
Revenues      
Cost of revenue      
Gross profit:      
Operating expenses(7,915)(5,230)(4,612)(3,669)(3,138)(3,275)
Operating loss:(7,915)(5,230)(4,612)(3,669)(3,138)(3,275)
Nonoperating income2753717624
Investment income, nonoperating2753 7624
Loss from continuing operations:(7,888)(5,177)(4,541)(3,593)(3,136)(3,271)
Loss before gain (loss) on sale of properties:(7,888)(5,177)(4,541)(3,593)(3,136)(3,271)
Net loss available to common stockholders, diluted:(7,888)(5,177)(4,541)(3,593)(3,136)(3,271)

Comprehensive Income ($ in thousands)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q3
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
Net loss:(7,888)(5,177)(4,541)(3,593)(3,136)(3,271)
Comprehensive loss, net of tax, attributable to parent:(7,888)(5,177)(4,541)(3,593)(3,136)(3,271)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: